Patent · US Active

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

US10695421B2 · kind B2 · utility

3Cited by
61References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2019
Grant dateJun 30, 2020
Priority date
Expiry dateFeb 5, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2730/10171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are nucleic acid sequences that encode novel consensus amino acid sequences of HBV core protein, as well as genetic constructs/vectors and vaccines that express said protein sequences. Also provided herein are methods for generating an immune response against HBV using the nucleic acid sequences that are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.